Harvard University

Overview

The Clinical Investigation programme at Harvard University is designed to equip students with the skills needed to lead patient-oriented and translational research. This comprehensive curriculum integrates rigorous coursework with hands-on research experience, preparing graduates to effectively design studies, analyze clinical data, and communicate their findings through academic writing and grant proposals. The programme typically spans 24 months and is delivered on-campus in Boston, Massachusetts.

What you'll study

The programme offers two primary tracks: Clinical Investigation and Translational Investigation. Students will complete a shared core curriculum in their first year before customizing their educational pathway in the second year.

Year 1 (Core learning)

• Clinical and Translational Investigation Thesis Preparation
• Clinical Data Science: Design and Analytics
• Leadership and Teamwork
• Genetic Epidemiology

Year 2 (Track customization + mentored research)

• Mentored Research Experience at a Harvard-based institution in Boston
• Clinical Data Science: Comparative Effectiveness Research
• Drug Development, Safety, and Translational Pharmacology

Capstone / thesis: The curriculum includes thesis preparation, culminating in a research thesis or an equivalent deliverable that is supported by the mentored research experience.

Learning approach: The programme emphasizes case studies, practical exercises, and research-led learning, connecting theoretical methods with real-world patient-oriented and translational research practices.

Entry requirements

While specific GRE, GMAT, or GPA requirements for this programme are not publicly detailed, prospective students should prepare to demonstrate their academic readiness and research potential through their application materials.

Career prospects

Graduates of the Clinical Investigation programme are well-prepared for careers in academic research, clinical trials, and healthcare innovation. They often pursue roles in academic institutions, healthcare organizations, and pharmaceutical companies, contributing to advancements in medical research and patient care.